W. Wingender
Impact in
- Biotechnology top 1%
- Enzyme Production and Characterization
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
-
- Enzyme Production and Characterization 5
- Co-authors
- Bodo Junge (4 shared papers)Delf Schmidt (4 shared papers)Ernst Truscheit (4 shared papers)Werner Frommer (3 shared papers)Lutz Müller (2 shared papers)Wolf B. Frommer (2 shared papers)P. Schacht (2 shared papers)D Förster (2 shared papers)
- Journals
- European Journal of Clinical Pharmacology (3 papers)The Journal of Antibiotics (1 paper)Journal of Hypertension (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Atherosclerosis (1 paper)
- Partner nations
- GermanyUnited StatesAzerbaijan
In The Last Decade
W. Wingender
24 papers receiving 1.2k citations
W. Wingender's Hit Papers
Peers
Comparison fields: 5 of 95
- Biotechnology 383
- Pharmacology 313
- Organic Chemistry 478
- Endocrinology, Diabetes and Metabolism 247
- Molecular Medicine 46
Countries citing papers authored by W. Wingender
This map shows the geographic impact of W. Wingender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Wingender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Wingender more than expected).
Fields of papers citing papers by W. Wingender
This network shows the impact of papers produced by W. Wingender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Wingender. The network helps show where W. Wingender may publish in the future.
Co-authors
The 25 scholars most cited alongside W. Wingender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemistry and Biochemistry of Microbial α‐Glucosidase Inhibitors Hit paper breakdown → | 1981 | 413 |
| 2 | ?-Glucosidase inhibitors Hit paper breakdown → | 1977 | 402 |
| 3 | 1981 | 130 | |
| 4 | 1984 | 126 | |
| 5 | 1970 | 66 | |
| 6 | Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin. | 1997 | 50 |
| 7 | 1988 | 24 | |
| 8 | 1988 | 23 | |
| 9 | Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1. | 1985 | 15 |
| 10 | 1974 | 12 | |
| 11 | 1992 | 10 | |
| 12 | 1992 | 6 | |
| 13 | 1998 | 5 | |
| 14 | 1975 | 5 | |
| 15 | 1987 | 4 | |
| 16 | 1997 | 4 | |
| 17 | 1988 | 3 | |
| 18 | 1989 | 2 | |
| 19 | 1988 | 2 | |
| 20 | 1983 | 2 |
About W. Wingender
W. Wingender is a scholar working on Molecular Biology, Biotechnology, Analytical Chemistry, Organic Chemistry and Pharmacology, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (5 papers), Enzyme Production and Characterization (5 papers), Epilepsy research and treatment (3 papers), Amino Acid Enzymes and Metabolism (3 papers), Carbohydrate Chemistry and Synthesis (3 papers), Diet and metabolism studies (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Chemical Reactions and Isotopes (2 papers). The work is most often cited by research in Biotechnology (383 citations), Pharmacology (313 citations), Organic Chemistry (478 citations), Endocrinology, Diabetes and Metabolism (247 citations) and Molecular Medicine (46 citations). W. Wingender has collaborated with scholars based in Germany, United States and Azerbaijan. Frequent co-authors include Bodo Junge, Delf Schmidt, Ernst Truscheit, Werner Frommer, Lutz Müller, Wolf B. Frommer, P. Schacht, D Förster, D. Beermann and Klaus Hofmann. Their work appears in journals such as European Journal of Clinical Pharmacology, The Journal of Antibiotics, Journal of Hypertension, Clinical Pharmacology & Therapeutics and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.